LOGIN  |  REGISTER
Chimerix
Viking Therapeutics

Dexcom Unveils Portrait Gallery to Portray Emotional Highs and Lows of Living With Diabetes on World Diabetes Day

November 14, 2023 | Last Trade: US$70.48 1.32 -1.84
  • Dexcom is helping the world #SeeDiabetes with a first-of-its-kind portrait gallery featuring the faces of people with diabetes from all walks of life and from all corners of the world, including celebrities Nick Jonas, Patti LaBelle and Jeremy Irvine.
  • The #SeeDiabetes campaign and portrait gallery supports Dexcom’s ongoing efforts to raise awareness for the need to expand access to critical diabetes technology, like CGM.
  • Since Dexcom’s #SeeDiabetes access and awareness campaign last November, coverage for CGM has expanded by 6 million people globally from 8 million to 14 million.1
  • Visit SeeDiabetes.com to view the digital portrait gallery for an intimate look into the highs and lows associated with living with an invisible disease.

SAN DIEGO & EDINBURGH, Scotland / Nov 14, 2023 / Business Wire / DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) systems for people with diabetes, is teaming up with Dexcom Warriors from around the globe to help raise awareness for the need to improve access to life-changing diabetes technology during National Diabetes Awareness Month in the U.S. and Canada (November) and on World Diabetes Day (November 14).

To shine a spotlight on the daily battle of living with diabetes, Dexcom unveiled a first-of-its-kind, global portrait gallery that gives an honest but hopeful look at people living with diabetes from all walks of life as they navigate the highs and lows of living with an invisible disease.

Brought to life by creative director, Dexcom Warrior, and Australian model Bambi Northwood-Blyth, and photographed by renowned portrait photographer Fernando Sippel, #SeeDiabetes: The Faces of Diabetes Warriors features Dexcom Warriors from around the world, each living with Type 1 or Type 2 diabetes. Dexcom CGM users whose portraits appear in the gallery include:

• Beth McDaniel and Ellen Watson, Northern Irish best friends and students

 

• Leontine de Hollander, Netherlands photographer

• Christian Mansell, Australian motorsports racing driver

 

• MiYeong Kim, Korean author and diabetes activist

• Georgiana Dumitra, Romanian lifestyle and beauty content creator

 

• Nick Jonas, American multi-platinum recording artist, songwriter, actor and philanthropist

• Jeremy Irvine, English actor

 

• Patti LaBelle, American legendary GRAMMY-winning artist, actress, author and entrepreneur

• Laura Sabourin, Canadian high school teacher

 

• Victor Garber, Canadian-American actor and singer

“As a Dexcom Warrior living with diabetes, it’s an honor to bring to life this unfiltered and genuine representation of what life is like for the millions of people living with diabetes globally,” said Northwood-Blyth. “In addition to the powerful imagery, each portrait is paired with a deeply personal narrative that highlights the realities of living with diabetes, and how access to technology like Dexcom CGM can lessen the burden of this disease and greatly improve your quality of life.”

The #SeeDiabetes campaign and portrait gallery reinforces Dexcom’s worldwide commitment to broaden access to critical diabetes technology and is aligned with the theme for World Diabetes Day 2021-23, ‘Access to Diabetes Care.’ Elevating broad awareness for the latest diabetes management technology is an essential part of Dexcom’s ongoing efforts to increase access and reimbursement for CGM around the world.

Since Dexcom’s #SeeDiabetes access and awareness campaign last November, reimbursement coverage for CGM has expanded by 6 million people globally from 8 million to 14 million people with significant coverage expansions in the United States, Canada, France and Japan. In addition, Dexcom has brought previously unavailable CGM systems to market in nearly 20 countries around the world over the last 12 months.1

Despite this significant progress, millions more people with diabetes still face challenges obtaining coverage for the CGM systems they need to manage their condition more confidently. #SeeDiabetes: The Faces of Diabetes Warriors gives people with diabetes a unique platform to continue the global conversation about the need to improve access to critical diabetes care and technology.

“Awareness efforts like #SeeDiabetes, paired with clinical evidence that demonstrates the life-changing benefits of CGM, has led to the expansion of access to CGM for millions more people over the years,” said Dexcom president and CEO Kevin Sayer. “Dexcom is committed to working with healthcare providers, private payors, governments and nonprofit organizations around the world to significantly expand access to CGM for people with all Types of diabetes.”

To get involved in the conversation, Dexcom is asking people to visit SeeDiabetes.com and to share their own portrait and story of how diabetes has impacted them or someone they know using the hashtag #SeeDiabetes.

About DexCom, Inc.

DexCom, Inc. empowers people to take real-time control of health through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, Calif., and with operations across Europe and select parts of Asia/Oceania, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom works to simplify and improve diabetes management around the world. For more information on Dexcom, visit www.dexcom.com.

1 Dexcom, data on file, 2023

Category: IR

Dexcom, Dexcom Follow, Dexcom Clarity, and Dexcom Share are registered trademarks of Dexcom, Inc. in the U.S., and may be registered in other countries. ©2023 Dexcom, Inc. All rights reserved.

photo

Chimerix

Stock Quote

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB